Mifepristone Versus Osmostic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks

Trial Profile

Mifepristone Versus Osmostic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Mifepristone (Primary) ; Misoprostol (Primary)
  • Indications Abortion; Induced abortion
  • Focus Therapeutic Use
  • Acronyms SaMi2
  • Most Recent Events

    • 21 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top